.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Anthony Kong

London, GB

King's College London

Vortrag

27.09.2023
P17
The real world experience in setting up the first superficial hyperthermia service using wIRA in the UK and a proposal of a prospective pilot study (ThermoRad) to assess the effectiveness and safety profile of adding superficial hyperthermia to palliative radiotherapy in locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) or cutaneous squamous cell carcinoma (cSCC) not suitable for radical treatment
Clinical Applications & Trials

Weitere Beteiligungen

27.09.2023
P17
The real world experience in setting up the first superficial hyperthermia service using wIRA in the UK and a proposal of a prospective pilot study (ThermoRad) to assess the effectiveness and safety profile of adding superficial hyperthermia to palliative radiotherapy in locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) or cutaneous squamous cell carcinoma (cSCC) not suitable for radical treatment
Clinical Applications & Trials